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Transcriptomics Data
Abstract
An important question in many biological applications, is to estimate or classify gene activity states
(active or inactive) based on genome-wide transcriptomics data. Recently, we proposed a Bayesian
method, titled MultiMM, which showed superior results compared to existing methods. In short, MultiMM
performed better than existing methods on both simulated and real gene expression data, confirming
well-known biological results and yielding better agreement with fluxomics data. Despite these promising
results, MultiMM has numerous limitations. First, MultiMM leverages co-regulatory models to improve
activity state estimates, but information about co-regulation is incorporated in a manner that assumes
that networks are known with certainty. Second, MultiMM assumes that genes that change states in the
dataset can be distinguished with certainty from those that remain in one state. Third, the model can be
sensitive to extreme measures (outliers) of gene expression. In this manuscript, we propose a modified
Bayesian approach, which addresses these three limitations by improving outlier handling and by
explicitly modeling network and other uncertainty yielding improved gene activity state estimates when
compared to MultiMM.
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Abstract— An important question in many biological
applications, is to estimate or classify gene activity
states (active or inactive) based on genome-wide
transcriptomics data. Recently, we proposed a
Bayesian method, titled MultiMM, which showed
superior results compared to existing methods. In
short, MultiMM performed better than existing
methods on both simulated and real gene expression
data, confirming well-known biological results and
yielding better agreement with fluxomics data.
Despite these promising results, MultiMM has
numerous limitations. First, MultiMM leverages coregulatory models to improve activity state estimates,
but information about co-regulation is incorporated in
a manner that assumes that networks are known with
certainty. Second, MultiMM assumes that genes that
change states in the dataset can be distinguished with
certainty from those that remain in one state. Third,
the model can be sensitive to extreme measures
(outliers) of gene expression. In this manuscript, we
propose a modified Bayesian approach, which
addresses these three limitations by improving outlier
handling and by explicitly modeling network and
other uncertainty yielding improved gene activity
state estimates when compared to MultiMM.
Keywords—Gene Regulation, Transcriptomics,
Bayesian Inference
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I. INTRODUCTION
Many approaches to analyzing genome-wide transcriptomics
data attempt to leverage the data by classifying genes into one
of two gene activity states: active (roughly speaking, the gene
product is part of an active cellular mechanism) or inactive
(the cellular mechanism is not active) [1]–[3]. Previous
methods were limited by (a) assuming similar activity state
expression thresholds across genes, such as in GIMME [4]
where a user-specified expression level is used to classify
gene activity states in any given experiment, (b) assuming
similar
proportions
of
active
genes
across
experiments/conditions, (c) ignoring a priori information
about potential gene co-regulation and (d) failing to
adequately incorporate statistical uncertainty in subsequent
inference about gene activity states.
Recently, we published a novel approach using a
Bayesian Gaussian mixture model, MultiMM [5]. Grounded in
a rigorous statistical framework, MultiMM addresses these
limitations as demonstrated by better performance than
existing methods on simulated and real transcriptomics data
and higher consistency with accepted biological results and
fluxomics data [4].The MultiMM algorithm takes as input a
genome-wide matrix of transcriptomics data E across many
experimental conditions and estimates the gene activity state
of each gene i in condition j. MultiMM allows for a priori
specification of sets of genes which are known to be coregulated so that they may be classified as all active or
inactive in the same experimental condition. Unlike previous
methods, the estimated mixture distribution parameters can be
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used to yield a posterior probability aij ∈ [0,1], that gene i is
active in condition j. Recently, we further demonstrated that
use of gene activity estimates outperformed the use of raw
expression data when conducting gene-set analysis approaches
to test for differential gene expression [6]. The promising
results of the MultiMM method, however, are tempered
somewhat by at least three significant limitations. First, the
MultiMM method assumed that a priori identification of coregulated genes was certain. This is rarely the case. Depending
on data quality, a priori sets of co-regulated genes are likely
often a mix of genes, which are co-regulated, are co-regulated
only in some conditions or are not co-regulated at all. Second,
in the first step of the method, inference about whether a gene
is changing states (mathematically, whether expression values
come from a one- or two-component mixture model) is taken
to be certain, but in reality these classifications are estimates.
Finally, inference about whether a gene’s expression values
are from one or two components, as well as the Gibbs
sampling method to estimate the model’s parameter values,
can be sensitive to extreme values (outliers). In this paper we
present enhancements to the MultiMM approach which
address the noted shortcomings of the existing method and
evaluate the modified method compared to the existing
MultiMM method.
II. METHODS
A. Modifications to the existing MultiMM Approach
The following three sections discuss limitations and
modifications to the MultiMM approach.
i. Hedging to improve inference about whether a gene is
changing activity states
The current MultiMM method [5] uses the Bayesian
Information Criterion (BIC) to assess the fit of one- or twocomponent Gaussian mixture models in order to determine if
evidence exists that a gene (or co-regulated set of p genes) is
not changing activity states across the set of experiments
being evaluated (in which case there is only one component).
Following Raftery [7], the MultiMM method assumes that the
2-component distribution is assumed to be the better fit unless
the 1-component model has at least a 12-point lower BIC.
Genes for which the 2-component distribution is a better fit
are classified as “changing state,” and genes for which the 1component distribution is a statistically significantly better fit
are classified as “not changing state.” In some cases, the
resulting activity state estimates vary dramatically depending
on whether a gene is classified changing-state or not (see, for
example, Figure 1). We would like to incorporate the
uncertainty of whether or not a gene is changing state in
downstream analyses. To do so, we introduce a modification
to the algorithm that both (a) provides a smoother transition
between the two approaches rather than a sharp cutoff; and (b)
“hedges” its estimates in cases of uncertain classifications,
providing more balanced predictions and more accurately
incorporating uncertainty in downstream parts of the MultiMM
procedure.

Figure 1. Top: expression data for E. coli gene ymjA
across 907 unique experiments, with its 1-component (a)
and its 2-component (b) fit overlaid. Bottom: activity
state estimates (aij) for ymjA in the 907 experiments,
according to the models presented in (a) (corresponding
to c) and (b) (corresponding to d), respectively. The
distribution of activity state estimates is quite different
based on which method is used, despite only having a
difference of 0.7 in BIC (representing strong uncertainty
in which model (a) or (b) is correct). Graph (c) suggests
that ymjA is inactive in most experiments, whereas graph
(d) suggests that ymjA is active in most experiments.
First, we let Ci represent the posterior probability that gene i is
truly changing state. We note that the current MultiMM
approach assumes that Ci ∈ {0,1}, indicating complete
confidence that the gene is not-changing-state (Ci =0) or is
changing-state (Ci =1) respectively and using BIC criterion
described above (12 point lower BIC per Raftery [7]). Next,
we define the “Normalized Bayes Factor” of a set of p (p ≥1)
co-regulated genes as

is the natural log of the Bayes Factor, K, for the
where
fit of the 1-component Gaussian distribution to the expression
data over the 2-component Gaussian distribution as calculated
by the R package Mclust [8] giving the difference in loglikelihood between the two models. Intuitively, -2 times the
natural log of the Bayes factor, K, is a common measure of
statistical evidence, and scaling by N (the number of
experiments) and p provides a standardized statistic across coregulated set size and number of experiments. We note that
the highest observed value of NBF on our real set of 907
expression arrays for over 4000 genes is approximately 0, and
the lowest observed value is -0.913, which was observed on
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the three genes in the araBAD operon. Previously, it has been
noted that strong biological and statistical evidence confirms
the araBAD genes are changing states over these 907
expression arrays [7]. We propose a piecewise linear mapping
from NBF to C,

where A and B are both constants such that A<B. In our
exploration of different cutoff choices (detailed results not
shown), we observe that for genes that do not change states
(true 1-component multivariate Gaussian distributions),
appears independent of N and rarely falls below -2p-3;
hence, reasonable choices for A and B are:
and
We now briefly describe how C is used in the generation of
gene activity state estimates. In short, this approach estimates
gene activity values assuming the gene (or set of co-regulated
genes) is from a 1-copmonent mixture and, separately, from a
2-component mixture and then combines the estimates
reflecting confidence in the estimates.
Step 1. For each a priori specified set of co-regulated genes H,
generate gene activity state estimates, a(2)ij, using the
MultiMM approach and assuming that the set is changing
states.
Step 2. For each gene, i in the set, find parameters µi and σi
describing the best-fit 1-component Gaussian distribution
using Mclust. Then, looking at the full list of genes for which
transciptomics data is available, make a list L (of length n) of
all genes g where σi ∈ σg ± 0.1 and either µi ∈ µ0,g ±0.1 or
µi ∈ µ1,g ±0.1.
Step 3. Generate n sets of gene activity state estimates for i,
one for each gene in L, as if i’s expression data came from the
other gene’s best-fit 2-component distribution. Let these
estimates be called a(1)ij for each gene i.
Step 4. For each gene i, activity state estimates are calculated
as
(3)

Step 5. Following the original MultiMM approach, for each
co-regulated gene set and each experimental condition, use the
average activity state estimates for each gene in the set as the
final activity state estimate for each of the set’s genes.
Note that this method reduces to the standard MultiMM
approach if Ci=1 or Ci =0.

ii. Incorporating uncertainty into a priori sets of co-regulated
genes
The MultiMM method fits a k-dimensional multivariate
Gaussian mixture model on expression data for a set of k
genes that are indicated to be co-regulated; a model which

assumes that, in any given condition j, all k genes in the set
will either be active or inactive. In cases where k=1, a
univariate Gaussian mixture model is fit to the data. The
limitation of this approach is that there is no consideration of
uncertainty in the a priori specified set of k genes [9]. To
allow for this uncertainty, we propose ConfMM, which takes
as input a single number Ch, ranging from 0 to 1 for each set of
co-regulated genes, representing the posterior probability that
the genes in h are in fact co-regulated. For a set of purportedly
co-regulated genes, h, ConfMM first conducts the MultiMM
approach on each gene in the set separately, producing gene
activity estimates Uij for each gene i and experimental
condition j, and then conducts MultiMM on the entire set of
genes as a unit, producing gene activity estimates Mij. For each
gene i and experimental condition j, ConfMM’s output gene
activity estimates are then given by
Ch*Mij + (1-Ch)* Uij, where H is the co-regulated set
containing i. Similar to the approach for modeling
uncertainty in whether or not a gene is changing states
(section i), here we take a weighted average of the gene
activity estimates to capture the uncertainty quantified by
C h.
iii. Outlier Handling
Gaussian mixture modelling can be sensitive to extreme
values in the data caused by measurement and other errors,
ultimately leading to biased estimates of gene activity status.
The current MultiMM approach takes the view that outliers are
biologically meaningful and not due to error. We propose two
potential methods for mitigating the influence of outliers on
downstream gene activity state estimates.
- SD(d): This approach first calculates the mean and the
standard deviation S of the expression data for each gene, and
then removes any observations greater than + d*S or less
than - d*S .
-Wins(d): This approach, called “winsorization” [10], is
similar to SD(d), but does not actually remove any
observations. Instead, any observations greater than + d*S
are imputed as + d*S, and likewise any observations less
than - d*S are imputed as - d*S. To evaluate
winsorization, we consider d= 4 and d=5.
B. Real Data Sets
We use genome-wide expression data comprising 4329 E. coli
genes from 907 different microarray data sets in a variety of
diverse conditions. Raw data from Affymetrix CEL files were
normalized using RMA [11] and these data were placed in the
M3D data repository [12]. Further details of data processing
are described in [13], [14]. E. coli operon predictions for 2648
operons (co-regulated gene sets), including 1895 single gene
operons, were obtained from Microbes Online [9].
C. Simulated data sets
For some analyses, we used simulated data with
characteristics based on the real set of 4329 E. coli genes
across 907 different experiments, with co-regulated sets of
genes based on prior predictions [9]. To mirror real expression
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data as closely as possible, we first screened the simulated
data and dropped all co-regulated sets of genes (operons) for
which the 2-component model did not yield the highest BIC.
A random selection of the remaining operons was chosen to be
single component in the simulated data with each of the single
component operons being always active or inactive with equal
likelihood. In order to demonstrate our method’s performance
in the face of uncertain operon classifications, we generated a
second simulated data set. We simulated 100, 3-gene sets over
907 experiments, where some proportion p of the 100 gene
sets were actually co-regulated, and the other 100(1-p) gene
sets were actually generated as independent genes. In each test
we then assigned confidence p to each of the 100 gene sets.
We will refer to this simulated data set as the Co-regulated
Confidence data.

separately. Finally, MultiMM(NBF) is the version of MultiMM
proposed earlier (i.) which uses NBF to estimate C.

E. Validation and statistical analysis
For simulated data, true gene activity states are known by
nature of the simulation. For real data, predictions of gene
activity were obtained using FVA [17] on the E. coli iJO1366
metabolic model [18]. For the purposes of evaluating the
performance of the methods we use the “mean square
alignment”, defined as
where x and y represent sets (usually matrices) of
probabilities, and the mean is taken over all i and j. Usually, x
will be a set of gene activity state estimates from the method
being evaluated, and y will be either the true gene activity
states (on simulated data) or the FVA predictions (on real
data). Higher mean square alignment indicates improved
agreement (that is, less difference) between the sets.
III. RESULTS

Figure 2. (a) Expression data for E. coli gene rhaB
across 907 diverse experiments; (b) expression data for gene
rhaB with its 2-component fit from MultiMM overlaid. The
current MultiMM method fits a 2-component model to this
gene with the ‘inactive’ component of the model fit to a small
number of very low expression values. Thus, the current
MultiMM method suggests that rhaB is active in most
experiments
D. Alternate gene activity state estimation methods
Following our earlier work [5], in this paper we
consider a variety of methods for inferring gene activity states:
MT (Median Threshold: all genes in an experiment above the
median are deemed active and, those below, inactive), TT
(Trichotomous Threshold: all genes below the 40th percentile
are deemed inactive, above the 60th percentile are active,
otherwise gene activity is deemed ‘uncertain’), and RB (Rankbased: the activity state estimate is the percentile rank within
the experiment). The MT approach can be found in [15]. TT is
an extension following GIMME which allows for an
“uncertain” classification as in [15], and RB is a further
extension in the spirit of GIM3E [16]. Further discussion of
such methods can be found elsewhere [5]. We also consider
alternatives to the MultiMM method: MultiMM(12) is the
standard MultiMM approach using a difference of 12 in BICs
to determine if a gene is changing state; MultiMM(0) is a
variation where no preference is given when selecting based
on BIC. UniMM is a univariate version of MultiMM that
simply discards all co-regulation data and processes each gene

A. Hedging to improve inference about whether a gene is
changing activity states
Figure 3 shows the mean square alignment between
various methods’ C estimates and the true classifications, on
the Sim-Uniform E. coli data. This shows that UniMM(NBF)
and MultiMM(NBF) provide the best overall performance
(measured as mean square alignment between the C values
and the true classifications) among univariate and multivariate
procedures, respectively.

Figure 3. Performance of various classification procedures
on Sim-Uniform E. coli data.
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B. Co-regulated gene set confidence levels
Figure 4 illustrates the performance of the ConfMM
method on the Co-regulated Confidence simulated data
described above. In particular, the performance of the three
methods are evaluated as the proportion of true co- regulated
genes in the set (p) varies. Notably, and by design, ConfMM is
as good as, or better than, both UniMM and MultiMM in every
case.

more biologically meaningful result as rhamnose is rarely
present in the 907 experiments considered here.

Figure 5. Performance of various outlier-handling
methods on real data. Coin flip is a random choice as to
whether the gene is active (50% chance) or inactive (50%
chance). In general, outlier handling improves mean square
alignment with SD and Wins methods performing relatively
similarly across methods.
Figure 4. Performance of UniMM, MultiMM and ConfMM
with varying levels of operon certainty.
C. Outlier Handling
Performance of each of the gene activity state
estimation methods with each of the outlier-handling
approaches, as measured by mean square alignment with the
FVA predictions on the real data, is given in Figure 5. We can
see an illustration of the effects of outlier-handling by
returning to rhaB, the gene from Figure 2. The raw expression
data for rhaB was shown in Figure 2(a); the expression data
after SD(4) or Wins(4) preprocessing is shown in Figure 6(a)
and 6(b) respectively. The series of unusually low
observations in Figure 2(a) were partially removed (by SD(4))
or made less extreme (by Wins(4)). In Figure 2(b) we saw that
in the raw expression data for rhaB (no outlier handling), the
series of unusually low observations was interpreted as an
‘inactive’ cluster, with the entire rest of the observations then
interpreted as ‘active’; this results in the gene activity
estimates shown in Figure 6(c) whereby rhaB is very
confidently identified as ‘active’ in the vast majority of
experiments. After SD(4) preprocessing, the expression data
for rhaB (shown in Figure 6(a)) was classified by MultiMM(0)
as not-changing-state, whereas the original expression data for
rhaB (shown in Figure 2(a)) had been classified by those
methods as changing-state, leading to the interpretation
explained earlier. This leads to substantially different gene
activity estimates, shown in Figure 6(d). If Wins(4)
preprocessing is used rather than SD(4), a third interpretation
results (see Figure 6(e)) in which rhaB is classified changingstate, but not due to the outliers on the left; instead, the overall
right-skewness of the expression data is interpreted as a large
‘inactive’ cluster and a small ‘active’ cluster, producing the
estimates shown in Figure 6(f). The outlier handling yields a

Figure 6. (a) and (b) Expression data for gene
rhaB following SD(4) and Wins(4) preprocessing
respectively; compare to Figure 2(a). (c) and (d)
Activity state estimates for rhaB in the 907
experiments according to MultiMM(0), with no
preprocessing or SD(4) preprocessing respectively.
(e) and (f) MultiMM(0) Wins(4) interpretation: 2component fit and generated activity state
estimates.
IV. Discussion
In this manuscript we have addressed three
limitations of the recently published MultiMM method for
inferring gene activity states from genome-wide
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transcriptomics data: (1) accounting for uncertainty in initial
inference about whether a gene is changing states, (2)
uncertainty in whether a set of genes is co-regulated and (3)
robustness to extreme gene expression values (outlier
handling). We demonstrated that on both real and simulated
data the new method performed better compared to the
existing MultiMM method.
The Bayesian modeling framework that we present in
this manuscript provides a flexible and adaptable approach to
infer gene activity. Thus, as additional sources of biological
information are obtained, they can be easily integrated into the
framework. Next steps include leveraging both empirical
estimates of gene co-regulation (e.g., correlation estimates
from the set of expression data) and more precise information
about regulatory relationships. One such relationship comes
from the Transcription Regulatory Network (TRN). A full
integration of TRN information would require the integration
of the relationships themselves and explicit incorporation of
TRN uncertainty into the Bayesian framework of the
MultiMM model.
Additional validation of these method refinements
and the original method are still necessary on organisms
beyond E. coli. Furthermore, many additional refinements are
possible including the incorporation of additional biological
information into the Bayesian model (e.g., cross-species gene
orthology, metabolic pathway information, etc.). Ultimately,
these gene activity estimates can be used in multiple
downstream applications including gene set analysis [6] and
metabolic flux modeling, among others. Software for the
methods illustrated here is available as supplemental files to
this manuscript and found here: http://www.dordt.edu/statgen.
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